Lee Sung 4
4 · CYTOKINETICS INC · Filed Jun 3, 2024
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Lee Sung
EVP, Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2024-05-31+53,417→ 53,417 totalExercise: $48.51From: 2025-06-02Exp: 2034-05-30→ Common Stock (53,417 underlying) - Award
Common Stock
2024-05-31+34,684→ 34,684 total
Footnotes (2)
- [F1]Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment.
- [F2]Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment.